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OBJECTIVES The aim of this study was to determine the prognostic value of right ventricular (RV) function
in patients after a myocardial infarction (MI).
BACKGROUND Right ventricular function has been shown to predict exercise capacity, autonomic imbalance
and survival in patients with advanced heart failure (HF).
METHODS Two-dimensional echocardiograms were obtained in 416 patients with left ventricular (LV)
dysfunction (ejection fraction [LVEF] 40%) from the Survival And Ventricular Enlarge-
ment (SAVE) echocardiographic substudy (mean 11.1  3.2 days post infarction). Right
ventricular function from the apical four-chamber view, assessed as the percent change in the
cavity area from end diastole to end systole (fractional area change [FAC]), was related to
clinical outcome.
RESULTS Right ventricular function correlated only weakly with the LVEF (r  0.12, p  0.013). On
univariate analyses, the RV FAC was a predictor of mortality, cardiovascular mortality and
HF (p  0.0001 for all) but not recurrent MI. After adjusting for age, gender, diabetes
mellitus, hypertension, previous MI, LVEF, infarct size, cigarette smoking and treatment
assignment, RV function remained an independent predictor of total mortality, cardiovascular
mortality and HF. Each 5% decrease in the RV FAC was associated with a 16% increased
odds of cardiovascular mortality (95% confidence interval 4.3% to 29.2%; p  0.006).
CONCLUSIONS Right ventricular function is an independent predictor of death and the development of HF
in patients with LV dysfunction after MI. (J Am Coll Cardiol 2002;39:1450–5) © 2002 by
the American College of Cardiology Foundation
The extent of left ventricular (LV) dysfunction is associated
with an adverse prognosis in patients with heart failure (HF)
and survivors of acute myocardial infarction (MI) (1–3). In
patients with moderate or advanced HF, right ventricular
(RV) dysfunction has been shown to predict a reduced
exercise capacity (4), autonomic imbalance (5) and short-
ened survival (6–12). Nevertheless, the significance of RV
dysfunction after MI is less clear (13–18).
The Survival And Ventricular Enlargement (SAVE) trial
demonstrated that patients with LV dysfunction after MI,
who were randomized to receive captopril, had improved
survival and a decreased incidence of HF and MI (19).
During the enrollment phase of the SAVE trial, an echo-
cardiographic substudy was prospectively designed to deter-
mine the importance of LV enlargement on outcome, as
well as the influence of captopril on LV size and the
patient’s clinical course (20,21). We studied the patients
enrolled in the SAVE echocardiographic substudy to deter-
mine the prognostic value of RV function in predicting
survival and the development of HF or MI in patients with
LV dysfunction, but free of HF, after MI.
METHODS
Study group. In the SAVE trial, 2,231 patients with LV
dysfunction (ejection fraction [LVEF] 40%), who were
free of right or left HF after MI, were randomized to receive
either captopril or placebo. Inclusion and exclusion criteria,
and the details of patients’ characteristics, have been previ-
ously described (19). Twenty-four of the original 45 centers
participated in the echocardiographic ancillary study. Pa-
tients with LVEF40%, but without signs of HF, and who
were 21 to 80 years old, were included in the study between
3 and 16 days after MI. The echocardiographic substudy
consisted of 512 patients who underwent two-dimensional
echocardiography at a mean time of 11.1  3.2 days after
MI (baseline) (20,21). Right ventricular images of sufficient
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quality for quantitative analysis of RV function were avail-
able in 416 patients.
Left ventricular analysis. All two-dimensional echocar-
diograms were submitted to the core laboratory at the
Brigham and Women’s Hospital for assessment of technical
quality and suitability for quantitative analysis (20). Left
ventricular size was assessed by measuring the LV cavity
areas at end diastole and end systole. Left ventricular
function was assessed as the percent change in the cavity
area from end diastole to end systole. The infarct location
was estimated by determining the location of akinesia or
dyskinesia, identified qualitatively on the echocardiogram
(20). In addition, LVEF was determined at baseline by
radionuclide ventriculography in all patients enrolled.
Right ventricular analysis. Right ventricular function was
assessed quantitatively, by echocardiographic analysis, as the
percent change in the cavity area from end diastole to end
systole. The RV free wall and septal endocardium were
digitized manually in the apical four-chamber view, utilizing
a custom-designed echocardiographic analysis program.
End diastole was identified by the onset of the R wave on
the simultaneously recorded electrocardiogram. End systole
was identified as the smallest RV cavity size just before
tricuspid valve opening. The RV free wall was traced from
the base to apex, and the RV areas were calculated from the
average of three measurements. Right ventricular fractional
area change (FAC) was calculated by using the following
formula: (end-diastolic area  end-systolic area)/end-
diastolic area (22). All measurements were performed by the
same observer (Dr. Zornoff), who had no knowledge of the
outcome data.
Normal RV function was determined by analysis of 50
patients who were identified as having normal echocardio-
grams (left and right), through a search of the laboratory
records at the Non-Invasive Laboratory at Brigham and
Women’s Hospital. We defined abnormal RV function as
RV FAC 2 SD below the mean value (32.2%). The
intraobserver reproducibility of the RV FAC measurement
was assessed by the primary reader performing two sets of
RV FAC measurements in 38 randomly selected patients, in
a blinded fashion. The correlation coefficient (r) between
the two assessments was 0.94 (coefficient of repeatability 
6.5%, by the Bland and Altman method). The interobserver
variability was assessed by a second experienced physician
who digitized and traced the RV areas in 16 randomly
selected patients; the correlation coefficient between the two
RV FAC measured was 0.83 (coefficient of repeatability 
8.8%, by the Bland and Altman method).
Statistical methods. To assess differences between the
groups, we used the Student t test for continuous variables
and the chi-square test for categorical variables. Logistic
regression was used to assess the relationship between RV
dysfunction and clinical outcome. The Kaplan-Meier
method was used to analyze the time to death and to
evaluate the crude effect of RV dysfunction. We used a Cox
proportional hazards ratio model (multivariate analysis) to
assess the relationship between baseline features and time-
dependent outcomes. This model included the following
variables known to influence the outcome after MI: age,
gender, diabetes mellitus, hypertension, previous MI,
LVEF (by either echocardiography or nuclear imaging
techniques), cigarette smoking, infarct size and treatment
assignment. Because the linearity assumption was not met
in the Cox regression model for the aforementioned con-
tinuous variables, we recoded them as dichotomous vari-
ables. The interaction between LV and RV function was
tested explicitly. A p value 0.05 was considered statisti-
cally significant. Statistical analyses were performed using
STATA software, version 7 (Stata Corp., College Station,
Texas).
RESULTS
The RV FAC in the normal study group ranged from 33.7%
to 66% (mean 46.53  7.18%) and was normally distrib-
uted. Thus, RV dysfunction in this study was defined as RV
FAC 32.2% (2 SD below the mean value for normal
subjects). The RV FAC in the SAVE population ranged
from 11.6% to 67% (mean 41.5  10.5%) and was also
normally distributed. Right ventricular dysfunction was
present in 79 patients (19%).
The baseline characteristics of the patients with and
without RV dysfunction are shown in Table 1. There were
no significant differences between the groups in terms of
age, gender distribution, frequency of diabetes, hypertension
or Killip class. The proportion of patients with a previous
MI was significantly higher in the RV dysfunction group,
and LVEF, as assessed by both radionuclide ventriculogra-
phy and echocardiography, was significantly lower in the
RV dysfunction group.
The RV FAC correlated only weakly, albeit significantly,
with LVEF (r 0.12, p 0.013). In addition, RV function
varied by infarct location (Table 2). Patients with an inferior
infarct location had a higher incidence of RV dysfunction
than those with an anterior infarct location, and RV FAC
was slightly lower in patients with an inferior infarct
location versus other locations (39.5 11% vs. 41.2 10%;
p  0.01).
Right ventricular function and outcome. For the com-
posite end point of death or HF, the mean duration of
follow-up was 671 days in the RV dysfunction group and
946 days in the group without RV dysfunction. During an
Abbreviations and Acronyms
FAC  fractional area change
HF  heart failure
LV  left ventricle or ventricular
LVEF  ejection fraction
MI  myocardial infarction
RV  right ventricle or ventricular
SAVE  Survival And Ventricular Enlargement trial
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average 2.6-year follow-up period, 79 patients died (67 from
cardiovascular causes), and 82 patients were either admitted
to the hospital or required open-label captopril for the
management of HF. The combined end point of cardiovas-
cular death or HF occurred in 130 patients (31.2%). A
recurrent MI occurred in 53 patients (12.7%). The relation-
ship between RV FAC and outcome after MI is shown in
Table 3. Patients with RV dysfunction demonstrated higher
total mortality, cardiovascular mortality and HF than pa-
tients without RV dysfunction. In contrast, there were no
differences in the incidence of recurrent MI between the two
groups. The Kaplan-Meier survival curves for patients with
and without RV dysfunction are shown in Figure 1.
In a Cox proportional hazards model, RV dysfunction
was a univariate predictor of total mortality, cardiovascular
mortality and HF (each p  0.0001) but not recurrent MI
(p  0.715). After adjusting for age, gender, diabetes
mellitus, hypertension, previous MI, LVEF (by both nu-
clear imaging and echocardiography), infarct size, cigarette
smoking and treatment assignment, RV dysfunction re-
mained an independent predictor of cardiovascular mortal-
ity, total mortality and HF (Table 4). Infarct location did
not modify the relationship between RV function and
outcome. Considering RV function as a continuous variable,
each 5% decrease in RV FAC was associated with a 16%
increased odds of cardiovascular mortality (95% confidence
interval [CI] 4.3% to 29.2%; p  0.006).
DISCUSSION
Left ventricular function is a known predictor of cardiovas-
cular morbidity and mortality after MI (1–3). The results of
this study demonstrate that RV FAC is also an independent
predictor of a poor outcome, including death and the
development of HF, in patients with LV dysfunction after
an acute MI. Thus, quantitative assessment of RV function,
often neglected clinically, may further stratify this high-risk
population.
Right ventricular function and outcome. Right ventricu-
lar dysfunction has been associated with an adverse outcome
in patients with HF (4–12) and may be secondary to
long-term exposure of the RV to chronic elevation of
left-sided pressures. The importance of RV function in
patients with acute MI is less clear. In a small study of 34
patients with clinically evident HF and coronary artery
disease, RVEF was a predictor of mortality (13). In contrast,
there was no relationship observed between RV function
and one-year mortality in a study of 423 patients, many of
Table 2. Relationship Between Infarct Location and Right
Ventricular Dysfunction
Infarct Location (n  415)
RV
Dysfunction
(n  79) RV FAC
Anterior (n  276) 16.7% 42.5  10%
Inferior only (n  70) 22.9% 40.1  10%
Anterior and inferior (n  52) 26.9% 38.7  11%
Any inferior (n  128) 24.2% 39.5  11%
Other (n  17) 11.8% 41.2  8.5%
FAC  fractional area change; RV  right ventricular.
Table 3. Relationship Between Right Ventricular Dysfunction
and Outcome
Outcome
No RV
Dysfunction
(n  337)
RV
Dysfunction
(n  79)
OR for RV
Dysfunction
(95% CI)
Death 14.5% 38.0% 3.6 (2.1–6.2)
CVD 12.2% 32.9% 3.5 (2.0–6.3)
HF 17.2% 30.4% 2.1 (1.2–3.7)
Death or HF 26.7% 50.6% 2.8 (1.7–4.7)
Recurrent MI 13.3% 10.1% 0.7 (0.3–1.6)
CVD  cardiovascular death; CI  confidence interval; HF  heart failure;
MI  myocardial infarction; OR  odds ratio; RV  right ventricular.
Table 1. Baseline Characteristics of Patients With and Without Right Ventricular Dysfunction
After Myocardial Infarction
No RV
Dysfunction
(n  337)
RV
Dysfunction
(n  79) p Value
Age (yrs) 58.5  11.1 60.3  10.6 0.185
Diabetes 17.5% 24.1% 0.18
Male 80.4% 83.5% 0.523
Hypertension 32.9% 27.8% 0.383
Previous MI 27.9% 50.6%  0.0001
LVEF (%) 31.5  5.9 29.8  7.3 0.0282
LV FAC (%) 29.1  5.8 26.3  6.5 0.0003
Current smoking 41.5% 35.4% 0.320
Killip class 2 34.1% 38.0% 0.518
Thrombolytic use 40.1% 29.1% 0.071
Infarct size* (%) 33.0  11 36.8  14 0.030
Inferior infarct 28.8% 39.2% 0.070
RV FAC (%) 45.2  7.8 25.8  4.8 By design
*Wall motion abnormalities/ventricular cavity, as assessed by echocardiography. Data are presented as the mean value  SD or
percentage of patients.
LVEF  left ventricular ejection fraction; LV FAC and RV FAC  left and right ventricular fractional area change,
respectively; MI  myocardial infarction, assessed by radionuclide ventriculography and echocardiography; RV  right
ventricular.
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whom had normal LV function (18). Furthermore, in the
TIMI-II trial (17), in which all patients received reperfu-
sion, a RV wall abnormality was detectable in only 5% of
patients with MI (n  1,110) and was not associated with
increased mortality in the year after hospital discharge.
However, only patients with inferior infarcts were included.
In the present study, in which all patients had LV dysfunc-
tion without HF, by study design, RV function indepen-
dently predicted mortality and the development of HF.
These data suggest that RV alterations can occur in a close
relationship to the LV alterations that accompany MI, an
observation that is supported by experimental evidence that
RV hypertrophy can develop very early after a large MI (23).
Etiology of RV dysfunction in MI. A number of possible
etiologies have been proposed to explain RV dysfunction
after acute MI. Left ventricular dysfunction is known to be
an important precursor of RV dysfunction (24), and the RV
is extremely sensitive to changes in afterload, a major
determinant of which is left atrial pressure (25). The greater
prevalence of RV dysfunction in patients with a previous MI
(50.6%) suggests that RV function may be a sensitive
integrator of left atrial pressure over time. Nevertheless, our
study, as well as others, suggests that RV function is largely
independent of LV function (15,18), and that RV dysfunc-
tion may be more dependent on the location and extent of
infarction than on the extent of LV dysfunction (26).
Right ventricular infarction or ischemia in the setting of
an inferior infarction could account for at least some of the
RV dysfunction seen in the present study. Right ventricular
infarction complicates 50% of cases of acute inferior MI
and is a predictor of major complications and mortality
(27,28). In this cohort, RV dysfunction was more frequent
in patients with an inferior MI. Nevertheless, the majority
of RV dysfunction (69%) in our study occurred in the
absence of inferior involvement and is therefore likely to be
due to other mechanisms. Finally, there is evidence from
other studies that RV function may recover to a great extent
after acute MI, suggesting that RV myocardial stunning
may also be implicated in the pathophysiology of RV
dysfunction after MI (16,29).
Although patients with long-standing HF often develop
pulmonary hypertension as an effect of elevated left-sided
pressures, our study suggests that RV function is largely
independent of LV systolic function, which in turn suggests
a substantial variability in the response of the RV to LV
dysfunction. It is unknown whether pre-existing pulmonary
parenchymal disease, vascular disease or diastolic LV dys-
function might contribute to RV dysfunction after MI,
although these factors may partly explain some of this
variability.
Study limitations. We estimated RV function as the per-
cent change in RV cavity area. Although there has been no
clear consensus by echocardiographers regarding the quan-
titative measurement of RV function, we and others have
used this measure in other studies (9,30). Because of the
complexity of RV geometry, volumetric approaches to RV
function have been problematic. Although assessment of
RV function from the apical four-chamber view is a rela-
tively simple technique, like all echocardiographic tech-
niques, it is dependent on image quality. Although a true
Figure 1. Cumulative percent survival of patients with and those without right ventricular (RV) dysfunction (fractional area change 32.2% or 32.2%).
HR  hazard ratio.
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volumetric validation of this method has not been per-
formed, the results of this analysis may be seen as a biologic
validation of this measure.
We cannot exclude the possibility that assessing RV
function at a different post-infarction time point would
reveal a different relationship between RV function and
outcome. It is likely that changes in RV function occur in
the first few weeks after MI, as do changes in LV function.
Although RV function at the time of randomization was a
good predictor of outcome in these patients, we cannot
specifically address the predictive value of RV function at
different periods after MI.
The results of this study need to be considered in light of
the unique patient population in SAVE because only
patients with LVEF 40% were included. Therefore, we
cannot simply extrapolate these data to patients with normal
LV function after MI. Another potential limitation of our
study is that we do not have data on the occurrence of RV
infarction, and we concede that RV infarction probably
accounts for some of the RV dysfunction in this cohort,
although given the preponderance of anterior infarcts, we do
not believe this could explain the majority of cases of RV
dysfunction.
Conclusions. Assessment of LV function has become
standard practice after MI, as this measure is a well-
recognized predictor of subsequent morbidity and mortality.
In contrast, quantitative clinical assessment of the RV after
MI is uncommon. The present study suggests that RV
function is an independent predictor of mortality and the
development of HF in patients with known LV dysfunction.
Thus, the estimation of RV function after MI may be
warranted in the standard assessment of post-infarct pa-
tients with LV dysfunction.
Reprint requests and correspondence: Dr. Scott D. Solomon,
Cardiovascular Division, Brigham and Women’s Hospital, 75
Francis Street, Boston, Massachusetts 02115. E-mail: ssolomon@
rics.bwh.harvard.edu.
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